Cost-effectiveness of statin treatment for primary prevention in conditions of real-world adherence - Estimates from the Finnish prescription register - UTU Tutkimustietojärjestelmä

A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä

Cost-effectiveness of statin treatment for primary prevention in conditions of real-world adherence - Estimates from the Finnish prescription register

Tekijät: Aarnio E, Korhonen MJ, Huupponen R, Martikainen J

Kustantaja: ELSEVIER IRELAND LTD

Julkaisuvuosi: 2015

Lehti:: Atherosclerosis

Tietokannassa oleva lehden nimi: ATHEROSCLEROSIS

Lehden akronyymi: ATHEROSCLEROSIS

Vuosikerta: 239

Numero: 1

Aloitussivu: 240

Lopetussivu: 247

Sivujen määrä: 8

ISSN: 0021-9150

DOI: https://doi.org/10.1016/j.atherosclerosis.2014.12.059

Tiivistelmä

Conclusions: Even though generic statins are now low-cost drugs, treatment adherence seems to have a major impact on the cost-effectiveness of statin treatment in primary prevention. This finding stresses the importance of making a concerted effort for improving adherence among patients on statin therapy to obtain full benefit of the investment in statins. Therefore, novel cost-effective approaches to improve treatment adherence are warranted. (C) 2015 Elsevier Ireland Ltd. All rights reserved.